earnings
confidence high
sentiment neutral
materiality 0.70
ICU Medical Q3 2024 revenue up 6.5% to $589.1M; GAAP net loss $33M, adj EPS $1.59
ICU MEDICAL INC/DE
2024-Q3 EPS reported
-$3.85
revenue$1,752,241,000
- Revenue $589.1M vs $553.3M YoY; GAAP gross margin improved to 34.8% from 33.2%.
- GAAP net loss $(33.0)M ($1.35 per diluted share) vs net income $7.2M ($0.30) in Q3 2023.
- Adjusted diluted EPS $1.59 vs $1.57 YoY; Adjusted EBITDA $94.8M vs $89.8M.
- Company updated FY2024 guidance; specific guidance numbers not fully disclosed in excerpt.